Trial · NCT04926844
Effectiveness of Combined Levetiracetam and Midazolam in Generalized Convulsive Status Epilepticus in Children
NCT04926844, Phase 2, Completed, Sohag University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effectiveness of Combined Levetiracetam and Midazolam in Generalized Convulsive Status Epilepticus in Children. Trials, record NCT04926844. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04926844
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effectiveness of Combined Levetiracetam and Midazolam in Generalized Convulsive Status Epilepticus in Children
- NCT number
- NCT04926844
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 144 participants, actual
- Lead sponsor
- Sohag University
- Conditions
- Status Epilepticus, Generalized Convulsive Status Epilepticus, Status Epilepticus, Generalized, Status Epilepticus, Generalized Convulsive
- Interventions
- Levetiracetam, Midazolam, Placebo
- First posted
- 2021-06-15
- Last updated
- 2022-09-21
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Cessation of seizures | 20 minutes | Cessation of clinical seizures at 20 minutes timepoint (end of first therapy phase) |
| Secondary | Need for repeating midazolam | 20 minutes | Need for repeating midazolam during the first therapy phase (5 - 20 min) |
| Secondary | Cessation of seizures | 40 minutes | Cessation of clinical seizures at 40 minutes timepoint (end of second therapy phase). |
| Secondary | Seizure control | 24 hours | 24-hours seizure control (no visually observed recurrence of seizures after the end of second phase therapy with improved sensorium) |
| Secondary | Hypotension | 24 hours | Occurrence of hypotension |
| Secondary | Need for mechanical ventilation | 24 hours | Need for mechanical ventilation |
| Secondary | Skin rash | 24 hours | Occurrence of skin rash |
| Secondary | Agitation/aggression | 24 hours | Occurrence of agitation/aggression |
| Secondary | Mortality | 24 hours | Occurrence of death |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers10
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04926844
GET https://conductscience.org/api/trials/v1/NCT04926844/registered